Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Sesen Bio stock

Learn how to easily invest in Sesen Bio stock.

Sesen Bio Inc is a biotechnology business based in the US. Sesen Bio shares (SESN) are listed on the NASDAQ and all prices are listed in US Dollars. Sesen Bio employs 35 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Sesen Bio

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SESN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Sesen Bio stock price (NASDAQ: SESN)

Use our graph to track the performance of SESN stocks over time.

Sesen Bio shares at a glance

Information last updated 2022-06-26.
Latest market close$0.82
52-week range$0.37 - $5.03
50-day moving average $0.55
200-day moving average $0.77
Wall St. target price$1.78
PE ratio 2.8996
Dividend yield $0 (0%)
Earnings per share (TTM) $0.28

Buy Sesen Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
Vanguard Personal Advisor
Stocks, Mutual funds, ETFs
$0
$0
N/A
Financial advice powered by relationships, not commissions.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sesen Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sesen Bio price performance over time

Historical closes compared with the close of $0.818 from 2022-06-24

1 week (2022-06-17) 7.63%
1 month (2022-05-25) 62.14%
3 months (2022-03-23) N/A
6 months (2021-12-23) -7.49%
1 year (2021-06-25) -80.38%
2 years (2020-06-26) 17.70%
3 years (2019-06-27) 1.6
5 years (2017-06-26) 1.51

Is Sesen Bio stock undervalued or overvalued?

Valuing Sesen Bio stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Sesen Bio's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Sesen Bio's P/E ratio

Sesen Bio's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Sesen Bio shares trade at around 3x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Sesen Bio financials

Revenue TTM $22.2 million
Gross profit TTM $1.2 million
Return on assets TTM -10.56%
Return on equity TTM 59.72%
Profit margin 244.53%
Book value $0.87
Market capitalisation $163.1 million

TTM: trailing 12 months

Sesen Bio share dividends

We're not expecting Sesen Bio to pay a dividend over the next 12 months.

Sesen Bio share price volatility

Over the last 12 months, Sesen Bio's shares have ranged in value from as little as $0.365 up to $5.03. A popular way to gauge a stock's volatility is its "beta".

SESN.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sesen Bio's is 0.8843. This would suggest that Sesen Bio's shares are less volatile than average (for this exchange).

Sesen Bio overview

Sesen Bio, Inc. , a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc.

Frequently asked questions

What percentage of Sesen Bio is owned by insiders or institutions?
Currently 0.432% of Sesen Bio shares are held by insiders and 22.557% by institutions.
How many people work for Sesen Bio?
Latest data suggests 35 work at Sesen Bio.
When does the fiscal year end for Sesen Bio?
Sesen Bio's fiscal year ends in December.
Where is Sesen Bio based?
Sesen Bio's address is: 245 First Street, Cambridge, MA, United States, 02142
What is Sesen Bio's ISIN number?
Sesen Bio's international securities identification number is: US8177631053
What is Sesen Bio's CUSIP number?
Sesen Bio's Committee on Uniform Securities Identification Procedures number is: 286221106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site